Skip to main content
Log in

Heterogeneity of longitudinal and circumferential contraction in relation to late gadolinium enhancement in hypertrophic cardiomyopathy patients with preserved left ventricular ejection fraction

  • Original Article
  • Published:
Japanese Journal of Radiology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate heterogeneity of myocardial contraction in relation to extensive late gadolinium enhancement (LGE) in hypertrophic cardiomyopathy (HCM) patients with preserved left ventricular ejection fraction, using fast strain-encoded magnetic resonance imaging.

Materials and methods

Twenty-two HCM patients and 24 age-matched control subjects were included in this retrospective study. The regional and global peak values of longitudinal and circumferential strain (LSregional, LSglobal, CSregional, CSglobal), and their regional heterogeneities were evaluated using coefficients of variation (LSCoV, CSCoV) in relation to LGE. Receiver operating characteristic curve analysis was performed to identify patients with a total left ventricular myocardial LGE ≥ 15%.

Results

LSglobal in HCM patients was significantly decreased compared to that in controls (− 14.4 ± 2.4% vs − 17.2 ± 2.0%; p = 0.0004), while CSglobal was not (p = 1.0). Negative LGE segments demonstrated decreased LSregional in HCM patients compared to in controls (p < 0.0001), while CSregional was not decreased. CSCoV demonstrated the largest area under the curve (AUC) (0.91), with high sensitivity (83%) and specificity (94%) for detection of HCM patients with extensive LGE, while the AUC of LSCoV was low (0.49).

Conclusion

The heterogeneity in CSregional has a high diagnostic value for detection of HCM patients with extensive LGE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. D’Andrea A, Caso P, Severino S, Cuomo S, Capozzi G, Calabro P, et al. Prognostic value of intra-left ventricular electromechanical asynchrony in patients with hypertrophic cardiomyopathy. Eur Heart J. 2006;27(11):1311–8.

    Article  PubMed  Google Scholar 

  2. Nagao M, Hatakenaka M, Matsuo Y, Kamitani T, Higuchi K, Shikata F, et al. Subendocardial contractile impairment in chronic ischemic myocardium: assessment by strain analysis of 3T tagged CMR. J Cardiovasc Magn Reson. 2012;14:14.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Nagao M, Yamasaki Y, Yonezawa M, Kamitani T, Kawanami S, Mukai Y, et al. Geometrical characteristics of left ventricular dyssynchrony in advanced heart failure. Myocardial strain analysis by tagged MRI. Int Heart J. 2014;55(6):512–8.

    Article  PubMed  Google Scholar 

  4. Young AA, Kramer CM, Ferrari VA, Axel L, Reichek N. Three-dimensional left ventricular deformation in hypertrophic cardiomyopathy. Circulation. 1994;90(2):854–67.

    Article  CAS  PubMed  Google Scholar 

  5. Neizel M, Lossnitzer D, Korosoglou G, Schaufele T, Lewien A, Steen H, et al. Strain-encoded (SENC) magnetic resonance imaging to evaluate regional heterogeneity of myocardial strain in healthy volunteers: comparison with conventional tagging. J Magn Reson Imaging. 2009;29(1):99–105.

    Article  PubMed  Google Scholar 

  6. Osman NF, Sampath S, Atalar E, Prince JL. Imaging longitudinal cardiac strain on short-axis images using strain-encoded MRI. Magn Reson Med. 2001;46(2):324–34.

    Article  CAS  PubMed  Google Scholar 

  7. Pan L, Stuber M, Kraitchman DL, Fritzges DL, Gilson WD, Osman NF. Real-time imaging of regional myocardial function using fast-SENC. Magn Reson Med. 2006;55(2):386–95.

    Article  PubMed  Google Scholar 

  8. Chan RH, Maron BJ, Olivotto I, Pencina MJ, Assenza GE, Haas T, et al. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation. 2014;130(6):484–95.

    Article  PubMed  Google Scholar 

  9. Kuo PH. Gadolinium-containing MRI contrast agents: important variations on a theme for NSF. J Am Coll Radiol. 2008;5(1):29–35.

    Article  PubMed  Google Scholar 

  10. Thomsen HS. ESUR guideline: gadolinium-based contrast media and nephrogenic systemic fibrosis. Eur Radiol. 2007;17(10):2692–6.

    Article  PubMed  Google Scholar 

  11. Oyama-Manabe N, Ishimori N, Sugimori H, Van Cauteren M, Kudo K, Manabe O, et al. Identification and further differentiation of subendocardial and transmural myocardial infarction by fast strain-encoded (SENC) magnetic resonance imaging at 3.0 Tesla. Eur Radiol. 2011;21(11):2362–8.

    Article  PubMed  Google Scholar 

  12. Saito M, Okayama H, Yoshii T, Higashi H, Morioka H, Hiasa G, et al. Clinical significance of global two-dimensional strain as a surrogate parameter of myocardial fibrosis and cardiac events in patients with hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2012;13(7):617–23.

    Article  PubMed  Google Scholar 

  13. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2011;58(25):e212–60.

    Article  CAS  PubMed  Google Scholar 

  14. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol. 2007;50(19):1914–31.

    Article  PubMed  Google Scholar 

  15. Goto D, Kinugawa S, Hamaguchi S, Sakakibara M, Tsuchihashi-Makaya M, Yokota T, et al. Clinical characteristics and outcomes of dilated phase of hypertrophic cardiomyopathy: report from the registry data in Japan. J Cardiol. 2013;61(1):65–70.

    Article  PubMed  Google Scholar 

  16. Shehata ML, Basha TA, Tantawy WH, Lima JA, Vogel-Claussen J, Bluemke DA, et al. Real-time single-heartbeat fast strain-encoded imaging of right ventricular regional function: normal versus chronic pulmonary hypertension. Magn Reson Med. 2010;64(1):98–106.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Liu D, Ma X, Liu J, Zhao L, Chen H, Xu L, et al. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine. Int J Cardiovasc Imaging. 2017;33(8):1191–200.

    Article  PubMed  Google Scholar 

  18. Reant P, Donal E, Schnell F, Reynaud A, Daudin M, Pillois X, et al. Clinical and imaging description of the Maron subtypes of hypertrophic cardiomyopathy. Int J Cardiovasc Imaging. 2015;31(1):47–55.

    Article  PubMed  Google Scholar 

  19. Carasso S, Yang H, Woo A, Vannan MA, Jamorski M, Wigle ED, et al. Systolic myocardial mechanics in hypertrophic cardiomyopathy: novel concepts and implications for clinical status. J Am Soc Echocardiogr. 2008;21(6):675–83.

    Article  PubMed  Google Scholar 

  20. Yang H, Carasso S, Woo A, Jamorski M, Nikonova A, Wigle ED, et al. Hypertrophy pattern and regional myocardial mechanics are related in septal and apical hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2010;23(10):1081–9.

    Article  PubMed  Google Scholar 

  21. Okada K, Yamada S, Iwano H, Nishino H, Nakabachi M, Yokoyama S, et al. Myocardial shortening in 3 orthogonal directions and its transmural variation in patients with nonobstructive hypertrophic cardiomyopathy. Circ J. 2015;79(11):2471–9.

    Article  PubMed  Google Scholar 

  22. Popovic ZB, Kwon DH, Mishra M, Buakhamsri A, Greenberg NL, Thamilarasan M, et al. Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging. J Am Soc Echocardiogr. 2008;21(12):1299–305.

    Article  PubMed  Google Scholar 

  23. Spirito P, Maron BJ, Bonow RO, Epstein SE. Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy. Am J Cardiol. 1987;60(1):123–9.

    Article  CAS  PubMed  Google Scholar 

  24. Ikeda H, Maki S, Yoshida N, Murohara T, Adachi H, Koga Y, et al. Predictors of death from congestive heart failure in hypertrophic cardiomyopathy. Am J Cardiol. 1999;83(8):1280–3.

    Article  CAS  PubMed  Google Scholar 

  25. Aly MF, Brouwer WP, Kleijn SA, van Rossum AC, Kamp O. Three-dimensional speckle tracking echocardiography for the preclinical diagnosis of hypertrophic cardiomyopathy. Int J Cardiovasc Imaging. 2014;30(3):523–33.

    Article  PubMed  Google Scholar 

  26. Almaas VM, Haugaa KH, Strom EH, Scott H, Smith HJ, Dahl CP, et al. Noninvasive assessment of myocardial fibrosis in patients with obstructive hypertrophic cardiomyopathy. Heart. 2014;100(8):631–8.

    Article  PubMed  Google Scholar 

  27. Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, et al. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA. 2007;298(4):405–12.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Noriko Oyama-Manabe.

Ethics declarations

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee.

Conflicts of interest

The authors declare that they have no conflict of interest.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sakamoto, K., Oyama-Manabe, N., Manabe, O. et al. Heterogeneity of longitudinal and circumferential contraction in relation to late gadolinium enhancement in hypertrophic cardiomyopathy patients with preserved left ventricular ejection fraction. Jpn J Radiol 36, 103–112 (2018). https://doi.org/10.1007/s11604-017-0700-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11604-017-0700-5

Keywords

Navigation